Recombinant baculovirus and method for using the same for preparing recombinant adeno-associated virus vector
A recombinant baculovirus, including: an adeno-associated virus Rep gene, an adeno-associated virus Cap gene, and an recombinant adeno-associated virus genome ITR-GOI (gene of interest) flanked by rAAV inverted terminal repeats (ITR). The ITR-GOI includes a 5′ terminal nucleic acid fragment and a 3′ terminal nucleic acid fragment. The ITR-GOI is linked to an expression cassette of the Cap gene and an expression cassette of the Rep gene through the 5′ terminal nucleic acid fragment and the 3′ terminal nucleic acid fragment, respectively.
1. A recombinant baculovirus, comprising: an adeno-associated virus (AAV) Rep gene, an AAV Cap gene, and a recombinant adeno-associated virus (rAAV) genome ITR-GOI (gene of interest) flanked by AAV inverted terminal repeats (ITR); wherein:
the ITR-GOI comprises a 5′ terminal nucleic acid fragment and a 3′ terminal nucleic acid fragment; and
the ITR-GOI is linked to an expression cassette of the Cap gene and an expression cassette of the Rep gene through the 5′ terminal nucleic acid fragment and the 3′ terminal nucleic acid fragment, respectively.
2. The recombinant baculovirus of claim 1 , wherein the Rep gene has a codon-optimized sequence.
3. The recombinant baculovirus of claim 2 , wherein the Rep gene has the sequence represented by SEQ ID NO: 1, SEQ ID NO: 2, or SEQ ID NO: 3.
4. The recombinant baculovirus of claim 1 , wherein the Cap gene has a codon-optimized sequence.
5. The recombinant baculovirus of claim 4 , wherein the Cap gene has the sequence represented by SEQ ID NO: 4, SEQ ID NO: 5, or SEQ ID NO: 6.
6. The recombinant baculovirus of claim 1 , wherein each of two ends of the rAAV genome ITR-GOI comprises an inverted terminal repeat (ITR) of the adeno-associated virus genome; and the gene of interest (GOI) is disposed between the two ends of the ITR-GOI.
7. The recombinant baculovirus of claim 1 , wherein the inverted terminal repeat (ITR) has a sequence represented by SEQ ID NO: 7.
8. The recombinant baculovirus of claim 1 , wherein the 5′ terminal nucleic acid fragment and the 3′ terminal nucleic acid fragment have a length of 80-140 bp.
9. The recombinant baculovirus of claim 1 , wherein the 5′ terminal nucleic acid fragment and the 3′ terminal nucleic acid fragment have a sequence represented by SEQ ID NO: 8 or SEQ ID NO: 9.
10. The recombinant baculovirus of claim 1 , wherein the adeno-associated virus is adeno-associated virus serotype 2.
11. A method for preparing a recombinant adeno-associated vims vector, the method comprising:
(a) constructing a baculovirus by integrating a target gene into a genome of the recombinant baculovirus of claim 1 ;
(b) infecting an isolated host cell with the baculovirus of (a) to produce a recombinant adeno-associated virus; and
(c) purifying the recombinant adeno-associated virus of (b).
12. The method of claim 11 , wherein in (a), a shuttle vector based on a baculovirus expression system is used.